FIELD: medicine.
SUBSTANCE: invention refers to medicine, more specifically to a new chemical compound, a 3-(2,2,2-trimethylhydrazinium)propionate derivative - 3-(2,2,2-trimethylhydrazinium)potassium propionate nicotinate, (CH3)3N+NHCH2CH2COOKRCOO--wherein R= , showing endothelioprotective activity.
EFFECT: derivative can find application in medicine in the integrated treatment for endothelial dysfunction correction in cardiovascular diseases.
1 cl, 2 ex, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
3-(2,2,2-TRIMETHYLHYDRAZINIUM) PROPIONATE DERIVATIVE - 3-(2,2,2-TRIMETHYLHYDRAZINIUM) POTASSIUM PROPIONATE GLYCINATE EXHIBITING ENDOTHELIOPROTECTIVE ACTIVITY | 2011 |
|
RU2467748C1 |
3-(2,2,2-TRIMETHYLHYDRAZINIUM) PROPIONATE DERIVATIVE - 3-(2,2,2-TRIMETHYLHYDRAZINIUM) POTASSIUM PROPIONATE 5-BROMNICOTINATE EXHIBITING ENDOTHELIOPROTECTIVE ACTIVITY | 2011 |
|
RU2467745C1 |
3-(2,2,2-TRIMETHYLHYDRAZINIUM) PROPIONATE DERIVATIVE - 3-(2,2,2-TRIMETHYLHYDRAZINIUM) POTASSIUM PROPIONATE 5-NICOTINATE HYDROXIDE EXHIBITING ENDOTHELIOPROTECTIVE ACTIVITY | 2011 |
|
RU2467744C1 |
3-(2,2,2-TRIMETHYLHYDRAZINIUM) PROPIONATE-NICOTINATE 3-(2,2,2-TRIMETHYLHYDRAZINIUM) POTASSIUM PROPIONATE DERIVATIVE EXHIBITING ANTIISCHEMIC ACTIVITY | 2011 |
|
RU2458054C1 |
3-(2,2,2-TRIMETHYLHYDRAZINIUM) PROPIONATE DERIVATIVE - POTASSIUM GLYCINATE 3-(2,2,2-TRIMETHYLHYDRAZINIUM) PROPIONATE | 2011 |
|
RU2457198C1 |
3-(2,2,2-TRIMETHYLHYDRAZINIUM) PROPIONATE-5-NICOTINATE HYDROXIDE 3-(2,2,2-TRIMETHYLHYDRAZINIUM) POTASSIUM PROPIONATE DERIVATIVE EXHIBITING ANTIISCHEMIC ACTIVITY | 2011 |
|
RU2457202C1 |
3-(2,2,2-TRIMETHYLHYDRAZINIUM) PROPIONATE-5-BROMNICOTINATE 3-(2,2,2-TRIMETHYLHYDRAZINIUM) POTASSIUM PROPIONATE DERIVATIVE EXHIBITING ANTIISCHEMIC ACTIVITY | 2011 |
|
RU2458690C1 |
METHOD OF PICAMILONUM-BASED CORRECTION OF ENDOTHELIAL DYSFUNCTION IN L-NAME INDUCED NITRIC OXIDE DEFICIENCY | 2008 |
|
RU2364393C1 |
METHOD FOR RECOMBINANT ERYTHROPOIETIN CORRECTION OF ENDOTHELIAL DYSFUNCTION IN L-NAME INDUCED NITROGEN OXIDE DEFICIENCY | 2009 |
|
RU2409873C1 |
METHOD OF TADALAFIL-BASED CORRECTION OF ENDOTHELIAL DYSFUNCTION IN L-NAME INDUCED NITRIC OXIDE DEFICIENCY | 2008 |
|
RU2364395C1 |
Authors
Dates
2012-10-27—Published
2011-08-08—Filed